Table 2.
Neurological adverse events for the overall cohort and the 3 treatment groups
Overall (n=90) | Clipping (n=50) | Coiling (n=19) | Stent-assisted coiling (n=21) | P-value | |
---|---|---|---|---|---|
Overall | 13 (14.4) | 10 (20.0) | 1 (5.3) | 2 (9.5) | 0.228 |
Major events | 2 (2.2) | 2 (4.0) | 0 (0) | 0 (0) | 0.667 |
Ischemic stroke | |||||
Major | 1 (1.1) | 1 (2.0) | 0 (0) | 0 (0) | |
Minor | 5 (5.6) | 2 (4.0) | 1 (5.3) | 2 (9.5) | |
Intracranial hemorrhage | |||||
Major | 1 (1.1) | 1 (2.0) | 0 (0) | 0 (0) | |
Minor | 2 (2.2) | 2 (4.0) | 0 (0) | 0 (0) | |
Seizure (minor event) | 4 (4.4) | 4 (8.0) | 0 (0) | 0 (0) | |
Symptomatic vasospasm | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Data are presented as number (%).